EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Evofem Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01−0.00 (-10.00%)
Close on Oct 19, 2026
- Market cap
- $865.23K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jun 16, 2023(first seen in filings) | 1-for-125 reverse | Earlier per-share figures multiplied by 125 |
| May 18, 2023 | 1-for-125 reverse | Earlier per-share figures multiplied by 125 |
| May 10, 2022(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| May 6, 2022 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Feb 26, 2018(first seen in filings) | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Jan 18, 2018 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |